Abstract | OBJECTIVE: CASE SUMMARY: DISCUSSION:
Daptomycin has previously been shown to be successful in treating methicillin-resistant Staphylococcus aureus-associated meningitis and other serious VRE and enterococcal infections. Higher than approved doses of daptomycin were used in 2 cases where in theory higher CSF concentrations would thus be obtained. Gentamicin and linezolid were added to daptomycin therapy based on in vitro data synergy results and because of documented successful treatment for VRE meningitis, respectively. CONCLUSIONS: The difficulty in treating VRE CSF infections involves both drug kinetics and microbial resistance factors, as well as external factors such as foreign bodies like shunts. This report highlighted 3 cases where daptomycin use in concert with either gentamicin or linezolid was successful in treating this infection. Additional controlled trials will be helpful in identifying the best strategies when using daptomycin to treat CSF infections.
|
Authors | Jennifer Le, P Brandon Bookstaver, Celeste N Rudisill, Mohamed G Hashem, Raza Iqbal, Charles L James, George Sakoulas |
Journal | The Annals of pharmacotherapy
(Ann Pharmacother)
Vol. 44
Issue 12
Pg. 2001-6
(Dec 2010)
ISSN: 1542-6270 [Electronic] United States |
PMID | 21119097
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Acetamides
- Gentamicins
- Oxazolidinones
- Vancomycin
- Linezolid
- Daptomycin
|
Topics |
- Acetamides
(administration & dosage, therapeutic use)
- Aged
- Daptomycin
(administration & dosage, therapeutic use)
- Drug Therapy, Combination
- Enterococcus faecium
(drug effects)
- Gentamicins
(administration & dosage, therapeutic use)
- Gram-Positive Bacterial Infections
(drug therapy)
- Humans
- Linezolid
- Male
- Meningitis, Bacterial
(drug therapy, microbiology)
- Middle Aged
- Oxazolidinones
(administration & dosage, therapeutic use)
- Vancomycin
(pharmacology)
- Vancomycin Resistance
(drug effects)
|